Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Patent
1995-06-07
1997-04-29
Wax, Robert A.
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
4352523, 4353201, 536 235, 536 243, C12P 2102, C12N 121, C12N 1563, C07H 2104
Patent
active
056248199
ABSTRACT:
The present invention relates to somatic mutations in the Multiple Tumor Suppressor (MTS) gene in human cancers and their use in the diagnosis and prognosis of human cancer. The invention further relates to germ line mutations in the MTS gene and their use in the diagnosis of predisposition to melanoma, leukemia, astrocytoma, glioblastoma, lymphoma, glioma, Hodgkin's lymphoma, CLL, and cancers of the pancreas, breast, thyroid, ovary, uterus, testis, kidney, stomach and rectum. The invention also relates to the therapy of human cancers which have a mutation in the MTS gene, including gene therapy, protein replacement therapy and protein mimetics. Finally, the invention relates to the screening of drugs for cancer therapy.
REFERENCES:
Aaronson, S.A. (1991). "Growth Factors and Cancer," Science 254:1146-1153.
Cairns, P., et al. (1994). "Homozygous Deletions of 9p21 in Primary Human Bladder Tumors Detected by Comparative Multiplex Polymerase Chain Reaction," Cancer Research 54:1422-1424.
Cannon-Albright, L.A., et al. (1992). "Assignment of a Locus for Familial Melanoma, MLM, to Chromosome 9p13-p22," Science 258;1148-1152.
Cannon-Albright, L.A., et al. (1994), "Localization of the 9p Melanoma Susceptibility Locus (MLM) to a 2-cM Region between D9S736 and D9S171," Genomics 23;265-268.
Cheng, J.Q., et al. (1993). "Homozygous Deletions within 9p21-p22 Identify a Small Critical Region of Chromosomal Loss in Human Malignant Mesotheliomas," Cancer Research 53:4761-4763.
Ebralidze, A., et al. (1989). "Isolation and characterization of a gene specifically expressed in different metastatic cells and whose deduced gene product has a high degree of homology to a Ca.sup.2+ -binding protein family," Genes & Development 3:1086-1093.
Fountain, J.W., et al. (1992). "Homozygous deletions within human chromosome band 9p21 in melanoma," Proc. Natl. Acad. Sci. USA 89:10557-10561.
Goldstein, A.M., et al. (1994). "Linkage of Cutaneous Malignant Melanoma/Dysplastic Nevi to Chromosome 9p, and Evidence for Genetic Heterogeneity," Am. J. Hum. Genet. 54: 489-496.
Gruis, N.A., et al. (1995). "Genetic Evidence in Melanoma and Bladder Cancers that p16 and p53 Function in Separate Pathways of Tumor Suppression," Am. J. Pathology 146:1199-1206.
Gu, Y., et al. (1993). "Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit," Nature 366:707-710.
Hannon, G.J. and Beach, D. (1994). "p15.sup.INK4B is a potential effector of TGF-.beta.-induced cell cycle arrest," Nature 371:257-260.
Harris, C.C. (1993). "p53: At the Crossroads of Molecular Carcinogenesis and Risk Assessment," Science 262:1980-1981.
Hinds, P.W., et al. (1994). "Function of a human cyclin gene as an oncogene," Proc. Natl. Acad. Sci. USA 91:709-713.
Hunter, T. (1993). "Braking the Cycle," Cell 75:839-841.
Kamb, A., et al. (1994). "Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus," Nature Genetics 8:22-26.
Kamb, A., et al. (1994). "A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor Types," Science 264:436-440.
Marx, J. (1994). "How Cells Cycle Toward Cancer," Science 263:319-321.
Marx, J. (1994). "New Tumor Suppressor May Rival p53," Science 264:344-345.
Matsushime, H., et al. (1992). "Identification and Properties of an Atypical Catalytic Subunit (p34.sup.PSK-J3 /cdk4) for Mammalian D Type G1 Cyclins," Cell 71:323-334.
Motokura, T., et al. (1991). "A novel cyclin encoded by a bcl1-linked candidate oncogene," Nature 350:512-515.
Nancarrow, D.J., et al. (1993). "Confirmation of Chromosome 9p Linkage in Familial Melanoma," Am. J. Hum. Genet. 53:936-942.
Nasmyth, K. and Hunt, T. (1993). "Dams and sluices," Nature 366;634-635.
Nobori, T., et al. (1994). "Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers," Nature 368:753-756.
Pardee, A.B. (1989). "G.sub.1 Events and Regulation of Cell Proliferation," Science 246: 603-608.
Parker, C. and Sherbet, G.V. (1992). "Modulators of intracellular Ca.sup.2+ and the calmodulin inhibitor W-7 alter the expression of metastasis-associated genes MTS1 and NM23 in metastatic variants in the B16 murine melanoma," Melanoma Research 2:337-347.
Parry, D., et al. (1995). "Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16.sup.INK4/MTS1 tumour suppressor gene product," EMBO J. 14:503-511.
Ruppert, J.M., et al. (1993). "Evidence for Two Bladder Cancer Suppressor Loci on Human Chromosome 9," Cancer Research 53:5093-5095.
Serrano, M., et al. (1993). "A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4," Nature 366:704-707.
Sherr, C.J. (1993). "Mammalian G1 Cyclins," Cell 73:1059-1065.
Tulchinsky, E., et al. (1992). "Transcriptional analysis of the mts1 gene with specific reference to 5' flanking sequences," Proc. Natl. Acad. Sci. USA 89:9146-9150.
van der Riet, P., et al. (1994). "Frequent Loss of Chromosome 9p21-22 Early in Head and Neck Cancer Progression," Cancer Research 54:1156-1158.
Walker, G.J., et al. (1994). "Refined localization of the melanoma (MLM) gene on chromosome 9p by analysis of allelic deletions," Oncogene 9:819-824.
Weaver-Feldhaus, J., et al. (1994). "Localization of a putative tumor suppressor gene by using homozygous deletions in melanomas," Proc. Natl. Acad. Sci. 91:7563-7567.
Xiong, Y., et al. (1993). "p21 is a universal inhibitor of cyclin kinases," Nature 366:701-704.
Cannon-Albright Lisa A.
Kamb Alexander
Skolnick Mark H.
Lau Kawai
Myriad Genetics Inc.
University of Utah Research Foundation
Wax Robert A.
LandOfFree
Germline mutations in the MTS gene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Germline mutations in the MTS gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Germline mutations in the MTS gene will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-704967